Equities

HUTCHMED (China) Ltd

HCM:LSE

HUTCHMED (China) Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)300.06
  • Today's Change10.06 / 3.47%
  • Shares traded11.80k
  • 1 Year change11.13%
  • Beta--
Data delayed at least 20 minutes, as of Apr 24 2024 08:27 BST.
More ▼

IC View

The last IC recommendation on HUTCHMED (China) Ltd shares was Buy at 227.00 on 31 Jul 2023Read the full article

Key statistics

As of last trade HUTCHMED (China) Ltd (HCM:LSE) traded at 300.06, -11.22% below its 52-week high of 338.00, set on Oct 30, 2023.
52-week range
Today
173.60Jun 23 2023338.00Oct 30 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open299.00
High303.00
Low299.00
Bid300.00
Offer303.00
Previous close290.00
Average volume106.86k
Shares outstanding871.26m
Free float456.29m
P/E (TTM)31.49
Market cap24.70bn HKD
EPS (TTM)0.9003 HKD
Data delayed at least 20 minutes, as of Apr 24 2024 08:27 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.